膝手術、人工膝關節疼痛管理治療藥的全球市場 - 各藥物、各流通管道、各地區:市場規模、佔有率、未來展望、機會分析 (2022年～2030年)

Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, by Drug, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年04月08日 | 出版商:

Coherent Market Insights | 英文 177 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球膝手術、人工膝關節疼痛管理治療藥市場的主要促進因素，是大企業為了產品開發、上市的研究開發活動擴大，及藥物的認證數量增加，全膝關節置換術增加等。

本報告提供全球膝手術、人工膝關節疼痛管理治療藥的市場相關分析，產品概要，及市場基本結構及促進、阻礙因素，新型冠狀病毒感染疾病 (COVID-19) 的影響，各藥物、各流通管道、各地區的市場趨勢預測，主要企業的簡介、市場佔有率等調查。

Many types of medicines are available to help control pain, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), Acetaminophen, etc. Medications help people feel more comfortable, allowing one to start moving sooner, get the strength back more quickly, and recover from knee surgeries and arthroplasty faster.

Furthermore, increasing number of total knee arthroplasty is expected to drive the market growth over the forecast period

For instance, according to data published by National Center for Biotechnology Information in 2017, the number of total knee arthroplasty is estimated to range between 60,000 and 70,000 per year in Brazil.

Market Dynamics

Increasing research and development activities by the key players for the development and launch of knee surgeries and arthroplasty pain management drugs are expected to drive the growth of the global knee surgeries and arthroplasty pain management therapeutics market over the forecast period.

For instance, in May 2021, Allay Therapeutics, a clinical-stage biotechnology company, pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced the first-ever clinical data showing non-opioid pain relief lasting two weeks after a single administration. The existing post-surgical pain products have shown effectiveness for a maximum of three days after a single dose. The data come from a Phase 1b/2a clinical study of Allay's first candidate, ATX-101, in development to treat pain after total knee arthroplasty (replacement) or TKA surgery.

Moreover, increasing approval of drug is also expected to boost the market growth. For instance, in march 2020, GlaxoSmithKline Plc. announced that the U.S. Food and Drug Administration had approved Advil Dual Action with Acetaminophen, as an (OTC) over-the-counter product for pain relief. Advil Dual Action gives relief for various symptoms and is the major formulation that merges acetaminophen and ibuprofen, 2 strong ingredients indicated for over-the-counter pain relief that work in different ways.

Key features of the study:

This report provides an in-depth analysis of the global knee surgeries and arthroplasty pain management therapeutics market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global knee surgeries and arthroplasty pain management therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc, Allay Therapeutics, Mallinckrodt, Johnson & Johnson, Zydus Cadila Healthcare Ltd., Novartis AG, Purdue Pharma, Delphis Pharmaceutical, Taj Pharmaceuticals Limited, GlaxoSmithKline plc, AbbVie Inc., and Aurobindo Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global knee surgeries and arthroplasty pain management therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global knee surgeries and arthroplasty pain management therapeutics market

Detailed Segmentation:

Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Drug:
Acetaminophen
COX-2 inhibitors
Opioids
Non-steroidal Anti-inflammatories
Ketamine
Others
Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Region:
North America
- By Drug
- Acetaminophen
- COX-2 inhibitors
- Opioids
- Non-steroidal Anti-inflammatories
- Ketamine
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- U.S.
- Canada
Latin America
- By Drug
- Acetaminophen
- COX-2 inhibitors
- Opioids
- Non-steroidal Anti-inflammatories
- Ketamine
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- By Drug
- Acetaminophen
- COX-2 inhibitors
- Opioids
- Non-steroidal Anti-inflammatories
- Ketamine
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- By Drug
- Acetaminophen
- COX-2 inhibitors
- Opioids
- Non-steroidal Anti-inflammatories
- Ketamine
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- By Drug
- Acetaminophen
- COX-2 inhibitors
- Opioids
- Non-steroidal Anti-inflammatories
- Ketamine
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- GCC
- Israel
- Rest of Middle East
Africa
- By Drug
- Acetaminophen
- COX-2 inhibitors
- Opioids
- Non-steroidal Anti-inflammatories
- Ketamine
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Pfizer Inc*
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Allay Therapeutics
- Mallinckrodt
- Johnson & Johnson
- Zydus Cadila Healthcare Ltd.
- Novartis AG
- Purdue Pharma
- Delphis Pharmaceutical
- Taj Pharmaceuticals Limited
- GlaxoSmithKline plc
- AbbVie Inc
- Aurobindo Pharma

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Opportunity
Impact Analysis
Number of Total Knee Arthroplasty Surgeries
Key Developments
Regulatory Scenario
PEST Analysis
Pipeline Analysis
Overview of Postoperative Pain Management Regimes for Total Knee Arthroplasty

4. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market - Impact of Coronavirus (Covid-19) Pandemic

COVID-19 Epidemiology
Overall Impact On Healthcare
Impact On Demand And Supply Analysis

5. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Drug, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Acetaminophen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
COX-2 inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Non-steroidal Anti-inflammatories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Ketamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Region, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
North America
- Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Region/Country, 2017 - 2030, (US$ Mn)
- South Africa
- Central Africa
- North Africa

8. Competitive Landscape

Competitive Snapshot
- Pfizer Inc*
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Allay Therapeutics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mallinckrodt
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Zydus Cadila Healthcare Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Purdue Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Delphis Pharmaceutical
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Taj Pharmaceuticals Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AbbVie Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aurobindo Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies